#35 Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
This article examines musculoskeletal injuries prevalent in female athletes and discusses conventional treatment modalities alongside emerging evidence for medical cannabis in injury recovery and pain management. The narrative centers on an elite athlete’s personal account of cannabis use for managing chronic pain and psychological symptoms associated with sports-related injuries, highlighting patient perspectives on therapeutic benefit. While anecdotal testimonials can raise clinician awareness about patient preferences and off-label cannabis use in athletic populations, they should not substitute for rigorous clinical evidence when counseling patients about efficacy and safety. Clinicians caring for female athletes should recognize that many may self-treat with cannabis for injury-related pain and mood symptoms, making it important to have informed discussions about potential benefits, risks, drug interactions, and legal status in their jurisdiction. The article underscores a gap between patient-reported experiences and the current evidence base, which remains limited for cannabis in sports medicine contexts. Clinicians should remain open to patient experiences while advocating for high-quality research to better understand cannabis’s role in athletic injury recovery and to establish evidence-based dosing and safety protocols for this population.
🏀 While anecdotal accounts from high-profile athletes regarding cannabis use for injury recovery and mental health deserve respectful consideration, they should not substitute for rigorous clinical evidence when making treatment recommendations. The article highlights genuine clinical challenges in managing chronic pain and psychological distress in athletes, conditions for which conventional therapies sometimes fall short, yet the evidence base for cannabis in these specific contexts remains limited and inconsistent. Important confounders include the placebo effect, concurrent use of other treatments, individual variation in cannabinoid metabolism and response, and the lack of standardized dosing or product quality in most jurisdictions. Healthcare providers should recognize that patient narratives reflecting subjective benefit can coexist with incomplete safety and efficacy data, particularly regarding long-term cognitive effects in younger athletes and potential impacts on sports performance or drug testing. A practical approach involves listening to patients’ experiences while maintaining evidence-based counseling about known risks and benefits, exploring conventional evidence-based options
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
